Brief: Cohbar Completes Phase 1A And Initiates Phase 1B Stage Of Clinical Trial Of Cb4211 Under Development For Nash And Obesity
05/11/2019 14:07
Nov 5 (Reuters) - CohBar Inc CWBR.O :
* COHBAR COMPLETES PHASE 1A AND INITIATES PHASE 1B STAGE OF
CLINICAL TRIAL OF CB4211 UNDER DEVELOPMENT FOR NASH AND OBESITY
Source text for Eikon: ID:nGNX77yRb1
Further company coverage: CWBR.O
((Briefs@thomsonreuters.com;))
Recent news on CohBar
See all newsBrief: CohBar, Inc. Q2 EPS USD -1.49
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma